Bioaffinity Technologies Inc (BIAF)

Feb 06, 2025

Zacks Initiates Coverage of bioAffinity With Neutral Recommendation - MSN

Feb 06, 2025

Feb 06, 2025

The Zacks Analyst Blog Highlights Amazon, Bank of America, Caterpillar, NVE and bioAffinity - Yahoo Finance

Feb 06, 2025

Feb 05, 2025

Top Research Reports for Amazon.com, Bank of America & Caterpillar - Yahoo Finance

Feb 05, 2025

Feb 05, 2025

bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 16.7% – Here’s Why - Defense World

Feb 05, 2025

Jan 30, 2025

Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 - GlobeNewswire

Jan 30, 2025

Jan 27, 2025

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Jan 27, 2025

Jan 24, 2025

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Jan 24, 2025

Jan 23, 2025

bioAffinity Technologies (BIAF) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025

Jan 22, 2025

BIOAFFINITY TECHNOLOGIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

Jan 22, 2025

Jan 22, 2025

bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test - Mugglehead

Jan 22, 2025

Jan 22, 2025

bioAffinity secures Australian patent for lung cancer test - MSN

Jan 22, 2025

Jan 22, 2025

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic - BioSpace

Jan 22, 2025

Jan 21, 2025

bioAffinity Technologies stock hits 52-week low at $0.65 - MSN

Jan 21, 2025

Jan 18, 2025

Biotech company CEO receives pay bump - San Antonio Business Journal

Jan 18, 2025

Jan 15, 2025

bioAffinity Technologies Increases CEO Maria Zannes’ Annual Base Salary to $300,000 - Defense World

Jan 15, 2025

Jan 14, 2025

bioAffinity Technologies Adjusts CEO Compensation Package - TipRanks

Jan 14, 2025

Jan 14, 2025

bioAffinity Technologies CEO receives salary increase - Investing.com

Jan 14, 2025

Jan 14, 2025

bioAffinity Technologies (NASDAQ:BIAFW) Trading Up 4.7% – Time to Buy? - Defense World

Jan 14, 2025

Jan 13, 2025

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung - BioSpace

Jan 13, 2025

Jan 13, 2025

bioAffinity's Breakthrough Lung Cancer Test Shows 92% Accuracy, Could Save Medicare $379M - StockTitan

Jan 13, 2025

Jan 10, 2025

Enlivex CEO to Showcase Breakthrough Allocetra Cell Therapy on Bloomberg TV Special Feature - StockTitan

Jan 10, 2025

Dec 26, 2024

**bioAffinity Technologies Reports Results of 2024 Special Meeting** - Defense World

Dec 26, 2024

Dec 24, 2024

bioAffinity Technologies (NASDAQ:BIAF) Shares Down 2% – Here’s Why - Defense World

Dec 24, 2024

Dec 21, 2024

bioAffinity Technologies Boosts Sales with CyPath Lung - Yahoo Finance

Dec 21, 2024

Dec 21, 2024

bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 25.7% – Time to Sell? - Defense World

Dec 21, 2024

Dec 20, 2024

San Antonio biotech company looks to expand in 2025 - The Business Journals

Dec 20, 2024

Dec 17, 2024

bioAffinity Tech to Showcase Breakthrough Lung Cancer Detection Test in Exclusive Investor Webinar - StockTitan

Dec 17, 2024

Dec 17, 2024

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19 - Business Wire

Dec 17, 2024

Dec 16, 2024

Flow Cytometry in Oncology Market is Likely to Increase At - openPR

Dec 16, 2024

Dec 13, 2024

bioAffinity Technologies stock hits 52-week low at $0.91 By Investing.com - Investing.com UK

Dec 13, 2024

Dec 12, 2024

William Bauta to Spearhead Product Development at bioAffinity Technologies - MPO-mag

Dec 12, 2024

Dec 12, 2024

bioAffinity Technologies Set for Continued Expansion in 2025 - BioSpace

Dec 12, 2024

Dec 12, 2024

BioAffinity Technologies Set for Continued Expansion in 2025 - Marketscreener.com

Dec 12, 2024

Dec 12, 2024

bioAffinity's CyPath® Lung Test Drives Explosive 1,750% Sales Growth; Projects Strong 2024 Revenue - StockTitan

Dec 12, 2024

Dec 11, 2024

bioAffinity Technologies Adds Japanese Patent to its IP Portfolio - MPO-mag

Dec 11, 2024

Dec 05, 2024

bioAffinity Technologies stock hits 52-week low at $1.03 By Investing.com - Investing.com UK

Dec 05, 2024

Dec 05, 2024

Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule - Business Wire

Dec 05, 2024

Nov 29, 2024

bioAffinity Technologies (NASDAQ:BIAFW) Stock Price Up 24.4% – Here’s What Happened - Defense World

Nov 29, 2024

Nov 27, 2024

BioAffinity Technologies files to sell 2.72M shares of common stock for holders - Nasdaq

Nov 27, 2024

Nov 21, 2024

bioAffinity Technologies stock hits 52-week low at $1.21 By Investing.com - Investing.com UK

Nov 21, 2024

Nov 20, 2024

BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 20, 2024

Nov 18, 2024

Earnings roundup: Rackspace struggles as Victory Capital surges - San Antonio Express-News

Nov 18, 2024

Nov 15, 2024

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Zenopa

Nov 15, 2024

Nov 15, 2024

bioAffinity Technologies Reports Strong Q3 Growth - TipRanks

Nov 15, 2024

Nov 14, 2024

bioAffinity Technologies stock hits 52-week low at $1.24 By Investing.com - Investing.com Canada

Nov 14, 2024